The European Union drugs regulator authorised Pfizer’s coronavirus vaccine for use on children aged from 5 to 11 years on Thursday, clearing the way for shots to be administered to millions of elementary school children on the continent amid a new wave of infections sweeping across Europe.
It is the first time the European Medicines Agency has cleared a COVID-19 vaccine for use in young children.
The agency said it recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.